AMENDMENT TO SEVERANCE AND CHANGE OF CONTROL AGREEMENTSeverance and Change of Control Agreement • May 18th, 2021 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
Contract Type FiledMay 18th, 2021 Company Industry JurisdictionTHIS AMENDMENT TO CHANGE OF CONTROL AGREEMENT between Elizabeth A. Tarka, M.D. (the "Executive") and Idera Pharmaceuticals, Inc. (''the Company'') shall be effective May 28, 2021 (the “Date of Termination”).